Treatment patterns, clinical and economic outcomes of patients with anaplastic lymphoma kinase-positive non-small cell lung cancer receiving ceritinib: a retrospective observational claims analysis

Objective: To describe patient characteristics, treatment patterns, healthcare resource utilization (HRU), and costs among patients with anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) receiving ceritinib in second or later line of therapy. Methods: Adult patients with N...

Descripción completa

Detalles Bibliográficos
Autores principales: Dalal, Anand A., Guerin, Annie, Mutebi, Alex, Culver, Kenneth W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5917332/
https://www.ncbi.nlm.nih.gov/pubmed/29707414
http://dx.doi.org/10.1080/21556660.2018.1445092

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5917332/
https://www.ncbi.nlm.nih.gov/pubmed/29707414
http://dx.doi.org/10.1080/21556660.2018.1445092

Ejemplares similares